Lv1
40 积分 2025-02-20 加入
Prevalence, characteristics, management, and outcomes of difficult-to-treat inflammatory bowel disease
9小时前
已完结
Difficult-to-treat inflammatory bowel disease: results from an international consensus meeting
9小时前
已完结
Combined Advanced Targeted Therapy in Inflammatory Bowel Diseases: An Extensive Update
1个月前
已完结
Who and how to choose combination therapy for inflammatory bowel disease: a comprehensive expert review
2个月前
已完结
The use of combination biological or small molecule therapy in inflammatory bowel disease: A retrospective cohort study
3个月前
已完结
Net Remission Rates with Biologic Treatment in Crohn’s Disease: A Reappraisal of the Clinical Trial Data
3个月前
已完结
The outcome of Crohn's disease patients refractory to anti-TNF and either vedolizumab or ustekinumab
3个月前
已完结
Loss of Response to Vedolizumab and Ability of Dose Intensification to Restore Response in Patients With Crohn’s Disease or Ulcerative Colitis: A Systematic Review and Meta-analysis
3个月前
已完结
IBD Matchmaking - Rational Combination Therapy
3个月前
已完结
皖公网安备34019202002308
